Page 2 - Drug Development Program News Today

/CNW/ - Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the "Company" or "Havn Life") a biotechnology company pursuing standardized extraction of...

Throughs and new break throughs and extending lives. the drug boosting the immune system and helping it fight cancer and my next guest is associate director for the drug development program. and thank you so much for joining us. between the next 1 or 2 years it will be the cause of death. how come. >> in the past we used xhemo therapy that kills cancer sales. and now we harness the bodys own immune system that potentially is less tox and i can more effective against the cancer. >> how does that ...